Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history

被引:12
作者
McDowell, Michelle E. [1 ]
Occhipinti, Stefano [1 ]
Gardiner, Robert A. [2 ,3 ]
Chambers, Suzanne K. [2 ]
机构
[1] Griffith Univ, Sch Appl Psychol, Griffith Hlth Inst, Mt Gravatt, Qld 4111, Australia
[2] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4072, Australia
[3] Royal Brisbane Hosp, Dept Urol, Brisbane, Qld, Australia
关键词
prostate cancer; family history; early detection; CANCER; RELATIVES; RISK; METAANALYSIS;
D O I
10.1111/j.1464-410X.2012.11050.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To describe how a family history of prostate cancer influences men's prostate cancer testing behaviours, information support preferences, and motives for testing. SUBJECTS AND METHODS Men with a fi rst-degree family history (239 men) and a comparison sample from the general population of Queensland, Australia (289) aged 40-65 years, and no prior history of cancer. Cross-sectional, retrospective survey assessing: prevalence of prostate-specifi c antigen (PSA) testing and digital rectal examination (DRE); discussion of prostate cancer risks and benefi ts with a physician; prostate cancer information needs and preferences; motivations for testing. RESULTS Men with a family history were more likely to report: having ever had a PSA test (odds ratio [OR] 4.98; 95% confi dence interval [CI] 3.16-7.85), more PSA tests in their lifetimes (b 1.04; SE 0.40; 95% CI 0.26-1.82); to have had a DRE (OR 2.23; 95% CI 1.54-3.23); to have spoken to a doctor about prostate cancer (OR 3.72; 95% CI 2.30-6.02); and to have instigated these discussions (OR 1.74; 95% CI 1.13-2.70). Most men from both groups did not recall any discussion of the ` cons ' of prostate cancer testing with a doctor. Men with a family history reported a greater desire for information about prostate cancer prevention than did men without a family history. CONCLUSIONS Men with a family history are more concerned about getting prostate cancer and are tested more often; however, information needs, discussions about prostate cancer, and motivations for testing are similar to those of all men. There appears to be a disparity between public health approaches that promote informed decision-making and what is happening in practice.
引用
收藏
页码:64 / 70
页数:7
相关论文
共 50 条
[21]   Classifying the Reasons Men Consider to be Important in Prostate-Specific Antigen (PSA) Testing Decisions: Evaluating Risks, Lay Beliefs, and Informed Decisions [J].
McDowell, Michelle E. ;
Occhipinti, Stefano ;
Chambers, Suzanne K. .
ANNALS OF BEHAVIORAL MEDICINE, 2013, 46 (03) :322-335
[22]   Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer [J].
Antwi, Samuel O. ;
Steck, Susan E. ;
Zhang, Hongmei ;
Stumm, Lareissa ;
Zhang, Jiajia ;
Hurley, Thomas G. ;
Hebert, James R. .
CANCER EPIDEMIOLOGY, 2015, 39 (05) :752-762
[23]   Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL [J].
Ang, Mann ;
Rajcic, Branimir ;
Foreman, Darren ;
Moretti, Kim ;
O'Callaghan, Michael E. .
BJU INTERNATIONAL, 2016, 117 :68-75
[24]   Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study [J].
Young, Grace J. ;
Harrison, Sean ;
Turner, Emma L. ;
Walsh, Eleanor I. ;
Oliver, Steven E. ;
Ben-Shlomo, Yoav ;
Evans, Simon ;
Lane, J. Athene ;
Neal, David E. ;
Hamdy, Freddie C. ;
Donovan, Jenny L. ;
Martin, Richard M. ;
Metcalfe, Chris .
BMJ OPEN, 2017, 7 (10)
[25]   Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis [J].
Kurahashi, Toshifumi ;
Miyake, Hideaki ;
Shinozaki, Masashi ;
Oka, Nobutoshi ;
Takenaka, Atsushi ;
Hara, Isao ;
Matsumura, Yosuke ;
Fujisawa, Masato .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (02) :345-349
[26]   Prediagnostic Prostate-specific Antigen Testing and Clinical Characteristics in Men with Lethal Prostate Cancer [J].
Arvendell, Markus ;
Bjornebo, Lars ;
Eklund, Martin ;
Falagario, Ugo Giovanni ;
Engel, Jan Chandra ;
Akre, Olof ;
Gronberg, Henrik ;
Nordstrom, Tobias ;
Lantz, Anna .
EUROPEAN UROLOGY OPEN SCIENCE, 2024, 62 :61-67
[27]   Screening for prostate cancer using prostate-specific antigen testing in Japanese men on hemodialysis [J].
Toshifumi Kurahashi ;
Hideaki Miyake ;
Masashi Shinozaki ;
Nobutoshi Oka ;
Atsushi Takenaka ;
Isao Hara ;
Yosuke Matsumura ;
Masato Fujisawa .
International Urology and Nephrology, 2008, 40 :345-349
[28]   Diagnostic tests in urology: percentage of free prostate-specific antigen (PSA) [J].
Yi, Yooni ;
Breau, Rodney H. ;
Witiuk, Kelsey ;
Neuberger, Molly M. ;
Dahm, Philipp .
BJU INTERNATIONAL, 2013, 111 (04) :683-685
[29]   Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature [J].
Faisal, Farzana A. ;
Sundi, Debasish ;
Pierorazio, Phillip M. ;
Ball, Mark W. ;
Humphreys, Elizabeth B. ;
Han, Misop ;
Epstein, Jonathan I. ;
Partin, Alan W. ;
Carter, H. Ballentine ;
Bivalacqua, Trinity J. ;
Schaeffer, Edward M. ;
Ross, Ashley E. .
BJU INTERNATIONAL, 2014, 114 (6B) :E120-E129
[30]   Patterns of prostate-specific antigen testing by remoteness of residence and socio-economic status: An Australian population-based study [J].
Calopedos, Ross J. S. ;
Bang, Albert ;
Baade, Peter ;
Yu, Xue Q. ;
Ruthven, Stephen ;
Patel, Manish I. ;
Smith, David P. .
AUSTRALIAN JOURNAL OF RURAL HEALTH, 2019, 27 (03) :216-223